Daily Stock Analysis, BASI, Bioanalytical Systems Inc, priceseries

Bioanalytical Systems Inc. Daily Stock Analysis
Stock Information
Open
1.99
Close
1.91
High
2.00
Low
1.90
Previous Close
1.96
Daily Price Gain
-0.05
YTD High
2.17
YTD High Date
Mar 21, 2019
YTD Low
1.26
YTD Low Date
Jan 11, 2019
YTD Price Change
0.57
YTD Gain
42.54%
52 Week High
2.59
52 Week High Date
Jul 2, 2018
52 Week Low
1.18
52 Week Low Date
Dec 21, 2018
52 Week Price Change
0.16
52 Week Gain
9.14%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 10. 2017
0.90
Feb 21. 2017
1.02
6 Trading Days
13.79%
Link
LONG
Feb 24. 2017
1.26
Mar 15. 2017
1.55
13 Trading Days
23.25%
Link
LONG
May 1. 2017
1.25
May 22. 2017
1.57
15 Trading Days
25.85%
Link
LONG
Nov 13. 2017
2.01
Dec 19. 2017
2.68
25 Trading Days
33.54%
Link
LONG
Jun 29. 2018
1.65
Jul 16. 2018
1.80
10 Trading Days
9.36%
Link
LONG
Feb 27. 2019
1.50
Apr 5. 2019
2.03
27 Trading Days
35.26%
Link
Company Information
Stock Symbol
BASI
Exchange
NasdaqCM
Company URL
http://www.basinc.com
Company Phone
3174634527
CEO
Philip A. Downing
Headquarters
Indiana
Business Address
2701 KENT AVE, WEST LAFAYETT, IN 47906-1382
Sector
Equity
Industry Category
Diversified Services
Industry Group
Research Services
CIK
0000720154
About

Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company operates through two business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

Description

Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, other North America, the Pacific Rim, Europe, and internationally. It operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. It also provides in vivo sampling services for the continuous monitoring of chemical changes in life; preclinical and pathology services; product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; and stability testing to establish and confirm product purity, potency, and shelf life. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.